The Origin

“It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.”

---Sir William Osler---

Monday, November 10, 2008

Epigenetics and the control of epithelial sodium channel expression in collecting duct.

Epigenetics and the control of epithelial sodium channel expression in collecting duct.

Kidney Int. 2008 Sep 24. [Epub ahead of print]

Zhang D, Yu ZY, Cruz P, Kong Q, Li S, Kone BC.
1Division of Nephrology, Hypertension and Renal Transplantation, University of Florida College of Medicine, Gainesville, Florida, USA.


In eukaryotic nuclei, genomic DNA is compacted with histone and nonhistone proteins into a dynamic polymer termed chromatin. Reorganization of chromatin structure through histone modifications, the action of chromatin factors, or DNA methylation, can profoundly change gene expression. These epigenetic modifications allow heritable and potentially reversible changes in gene functioning to occur without altering the DNA sequence, thus extending the information potential of the genetic code. This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for aldosterone signaling and the control of epithelial Na(+) channel-alpha (ENaCalpha) subunit gene expression in the collecting duct. This new pathway involves a nuclear repressor complex, consisting of histone H3 Lys-79 methyltransferase disruptor of telomeric silencing-1a (Dot1a), ALL1 fused gene from chromosome 9 (Af9), a sequence-specific DNA-binding protein that binds the ENaCalpha promoter, and potentially other nuclear proteins. This complex regulates targeted histone H3 Lys-79 methylation of chromatin associated with the ENaCalpha promoter, thereby suppressing its transcriptional activity. Aldosterone disrupts the Dot1a-Af9 interaction by serum- and glucocorticoid-induced kinase-1 phosphorylation of Af9, and inhibits Dot1a and Af9 expression, resulting in histone H3 Lys-79 hypomethylation at specific subregions, and derepression of the ENaCalpha promoter. The Dot1a-Af9 pathway may also be involved in the control of genes implicated in renal fibrosis and hypertension.Kidney International advance online publication, 24 September 2008; doi:10.1038/ki.2008.475.
PMID: 18818687 [PubMed - as supplied by publisher]


2 comments:

Unknown said...

Epigenetic (biofield) control system of the organism is a most complex polyfuntional organization.

Please see my article in the BOOK at www.misaha.com

Savely Savva
831-622-7975
misaha@aol.com

Anonymous said...

You have some interesting information.